ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1148

The Role of TRPC6 in CXCR2-Mediated Chondrocyte Phenotypic Stability

Joanna Sherwood1, Jessica Bertrand1, Francesco Dell'Accio2 and Thomas Pap3, 1Institute for Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany, 2EMR, Queen Mary's School of Medicine and Dentistry, London, United Kingdom, 3Institute of Experimental Musculoskeletal Medicine, University Hospital Münster, Münster, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Calcium, cartilage, chemokines, chondrocytes and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint Poster I: Osteoarthritis Pathogenesis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: We have recently demonstrated that ELR+ CXC chemokines signaling via the CXCR2 receptor, are produced by healthy chondrocytes and are retained within the cartilage matrix via interactions with heparan sulfate proteoglycans.  They act to support articular cartilage homeostasis by increasing AKT phosphorylation, thus promoting SOX9 expression, extracellular matrix production and chondrocyte survival, particularly during conditions of physiological challenge, indicated by increased chondrocyte apoptosis and cartilage degradation in CXCR2-/- mice following destabilization of the medial meniscus.  Importantly, the transient receptor potential channel 6 (TRPC6) mechanosensitive ion channel has been shown to be a specific mediator of CXCR2 driven cell migration via AKT signaling.  This project aims to investigate whether TRPC6 activity is required for chondrocyte phenotypic stability and is involved in the mechanism of CXCR2-mediated cartilage homeostasis.

Methods: Costal chondrocytes were isolated from CXCR2-/- mice, TRPC6-/- mice and their wild type littermates and expanded in standard conditions.  Gene expression was assessed using real time RT-PCR.  Sulfated proteoglycan content and mineralization of micromass cultured chondrocytes was measured using Alcian blue or alizarin red staining and spectrophotometric quantification.  CXCR2 was activated using murine CXCL6 whilst TRPC6 was specifically activated using hyp9, a stabilized derivative of the TRPC6-selective activator hyperforin.  Intracellular calcium was chelated by treating cells with BAPTA-AM prior to receptor activation.  AKT phosphorylation was analyzed using Western blot. Calcium mobilization in chondrocytes was measured using a fura-2 assay.

Results: TRPC6 mRNA was detected in wild type murine chondrocytes.  Chondrocytes lacking either TRPC6 or CXCR2 expressed lower levels of the chondrocyte differentiation markers SOX9 and type II collagen in comparison to wild type.  Culture of chondrocytes in micromass resulted in significantly less sulfated proteoglycan production and increased mineralization by TRPC6-/- chondrocytes in comparison to chondrocytes obtained from wild type littermates. Activation of CXCR2 in articular chondrocytes resulted in increased intracellular calcium mobilization.  In vitro activation of TRPC6 using hyp9 led to an increased AKT phosphorylation, whereas chelation of intracellular calcium inhibited CXCL6-induced phosphorylation of AKT.  Finally, activation of TRPC6 resulted in a significant increase in SOX9 and type II collagen mRNA expression, together with a decrease in type X collagen mRNA expression.

Conclusion: TRPC6 calcium channel activity is required for chondrocyte phenotypic stability.  In vitro TRPC6 activation is sufficient to increase AKT phosphorylation and the expression of key chondrocyte phenotypic markers in murine chondrocytes, indicating that TRPC6 may be an ideal therapeutic target aimed at preventing cartilage degradation during osteoarthritis.


Disclosure: J. Sherwood, None; J. Bertrand, None; F. Dell'Accio, None; T. Pap, None.

To cite this abstract in AMA style:

Sherwood J, Bertrand J, Dell'Accio F, Pap T. The Role of TRPC6 in CXCR2-Mediated Chondrocyte Phenotypic Stability [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-role-of-trpc6-in-cxcr2-mediated-chondrocyte-phenotypic-stability/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-trpc6-in-cxcr2-mediated-chondrocyte-phenotypic-stability/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology